Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 15/20 | 0.51 |
| ▸ | NPY1R | P25929 | 9/20 | 0.51 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.51 |
| ▸ | NPY2R | P49146 | 5/20 | 0.51 |
| ▸ | MME | P08473 | 3/20 | 0.42 |
| ▸ | NMT2 | O60551 | 1/20 | 0.39 |
| ▸ | NMT1 | P30419 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30417026 | 1.00 | NPY4R (0.51) | NPY4RNPY1RNPY5RNPY2RMME | |
| SCHEMBL9561366 | 1.00 | NPY4R (0.51) | NPY4RNPY1RNPY5RNPY2RMME | |
| SCHEMBL30606210 | 0.99 | NPY4R (0.52) | NPY4RNPY1RNPY5RNPY2RMME | |
| SCHEMBL30042675 | 0.95 | NPY4R (0.53) | NPY4RNPY1RNPY5RNPY2RMME | |
| SCHEMBL29794238 | 0.94 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29871013 | 0.94 | NPY4R (0.56) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL7159410 | 0.94 | NPY4R (0.53) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29492567 | 0.94 | NPY4R (0.53) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL27712094 | 0.94 | NPY4R (0.53) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29492562 | 0.94 | NPY4R (0.53) | NPY4RNPY1RNPY5RNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116555283-A | Japanese larch LkZFP36 gene and protein encoded by same, application, over-expression vector and acquisition method | 东北林业大学 | 2023-08-08 | — | — | CN | disclosed |
| EP-4003533-A1 | METHODS OF TREATING MULTIFOCAL CANCER | Nymox Corporation (US) | 2022-06-01 | — | — | EP | disclosed |
| EP-4003387-A1 | FOCAL TREATMENT OF PROSTATE CANCER | Nymox Corporation (US) | 2022-06-01 | — | — | EP | disclosed |
| CN-113735968-A9 | Method for measuring titer of swine transmissible gastroenteritis virus N protein antibody | 山东畜牧兽医职业学院 | 2022-04-29 | — | — | CN | disclosed |
| CN-113740528-A9 | Swine transmissible gastroenteritis virus antibody detection kit | 山东畜牧兽医职业学院 | 2022-04-26 | — | — | CN | disclosed |
| EP-3969030-A1 | METHOD OF ENHANCING THE THERAPEUTIC EFFICACY OF FEXAPOTIDE TRIFLUTATE IN TREATING LUTS | Nymox Corporation (US) | 2022-03-23 | — | — | EP | disclosed |
| EP-3969112-A1 | METHOD OF TREATING LOWER URINARY TRACT SYMPTOMS WITH FEXAPOTIDE TRIFLUTATE | Nymox Corporation (US) | 2022-03-23 | — | — | EP | disclosed |
| EP-0346460-B1 | PURINE DERIVATIVES HAVING PHARMACOLOGICAL ACTION | CO PHARMA CORPORATION (IT) | 1993-03-10 | — | — | EP | disclosed |
| US-5110798-A | Immunomodulators for bone marrow transplants | CO PHARMA CORPORATION S.R.L. (IT) | 1992-05-05 | — | — | US | disclosed |
| EP-0346460-A1 | PURINE DERIVATIVES HAVING PHARMACOLOGICAL ACTION. | CO PHARMA CORP SRL (IT) | 1989-12-20 | — | — | EP | disclosed |
| WO-1989005818-A1 | PURINE DERIVATIVES HAVING PHARMACOLOGICAL ACTION | CO PHARMA CORPORATION S.R.L. (IT) | 1989-06-29 | — | — | WO | disclosed |